Literature DB >> 9040331

Potentiation of warfarin anticoagulant activity by miconazole oral gel.

S Ariyaratnam1, N S Thakker, P Sloan, M H Thornhill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040331      PMCID: PMC2125823          DOI: 10.1136/bmj.314.7077.349a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women.

Authors:  Mia Birkhøj Kjærstad; Flemming Nielsen; Lene Nøhr-Jensen; Stine Zwisler; Kim Brøsen; Helle Raun Andersen
Journal:  Eur J Clin Pharmacol       Date:  2010-10-06       Impact factor: 2.953

2.  Interaction between warfarin and topical miconazole cream.

Authors:  A Devaraj; J P O'Beirne; R Veasey; A A Dunk
Journal:  BMJ       Date:  2002-07-13

Review 3.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

4.  Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4.

Authors:  Juha Grönlund; Teijo I Saari; Nora Hagelberg; Pertti J Neuvonen; Klaus T Olkkola; Kari Laine
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

Review 5.  Drug and dietary interactions of warfarin and novel oral anticoagulants: an update.

Authors:  Edith Nutescu; Ittiporn Chuatrisorn; Erika Hellenbart
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

6.  Morbidity and mortality associated with the interaction of miconazole oral gel and warfarin.

Authors:  M N Pemberton
Journal:  Br Dent J       Date:  2018-07-27       Impact factor: 1.626

7.  Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib.

Authors:  Ville V Hynninen; Klaus T Olkkola; Pertti J Neuvonen; Kari Laine
Journal:  Eur J Clin Pharmacol       Date:  2008-09-09       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.